Price
572.95
+1.93%52W Range
Market Cap
₹485.00 Cr
Traded: ₹1.43 Cr (0.29%) 0.0x
Free Float: ₹225.91 Cr (0.63% of FF traded)
Volume · 60D trend
25.73 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +13.0% | +13.0% | -- | +25.0% | Stable |
| ROE | -- | +7.0% | +7.0% | -- | -- | Stable |
| Return | -- | -23.0% | -13.0% | -28.0% | -- | Stable |
| Profit | -- | -11.0% | -1.0% | -- | +46.0% | Accelerating |
Quarterly Results
Mar 2023
Dec 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 273 | 256 | 208 | 179 | 216 | 202 | 163 | 151 | 143 | 159 | 139 | 144 | 149 | 158 | 134 |
| Expenses | 253 | 243 | 195 | 170 | 204 | 182 | 154 | 147 | 134 | 144 | 122 | 128 | 134 | 144 | 120 |
| Operating Profit | 20 | 13 | 13 | 9 | 12 | 20 | 9 | 4 | 10 | 14 | 17 | 16 | 15 | 14 | 14 |
| OPM % | 7.4% | 5.2% | 6.1% | 5.2% | 5.4% | 9.8% | 5.5% | 2.5% | 6.7% | 9.0% | 12.1% | 11.3% | 9.9% | 8.8% | 10.2% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 | -0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 3 | 4 | 4 |
| Depreciation | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Profit Before Tax | 12 | 6 | 5 | 2 | 4 | 13 | 1 | 3 | 3 | 7 | 9 | 9 | 8 | 6 | 5 |
| Tax % | 26.2% | 28.7% | 28.2% | 29.2% | 27.2% | 26.2% | 33.9% | 40.1% | 32.9% | 31.2% | 26.4% | 45.9% | 30.6% | 23.9% | 27.1% |
| Net Profit | 9 | 4 | 4 | 2 | 3 | 10 | 1 | 2 | 2 | 5 | 7 | 5 | 5 | 5 | 4 |
| Exceptional Items | -- | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Rs) | 10.6 | 5.0 | 4.3 | 1.8 | 3.5 | 11.5 | 0.9 | 2.1 | 2.6 | 5.5 | 7.9 | 5.6 | 6.2 | 5.5 | 4.7 |
| Sales Growth (YoY) | 26.4% | 26.8% | 27.6% | 18.8% | 50.5% | 27.4% | 17.3% | 4.8% | -3.6% | 0.5% | 3.9% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 6.5% | 23.3% | 16.0% | -17.0% | 6.8% | 24.1% | 7.9% | 5.2% | -9.6% | 14.3% | -3.5% | -3.3% | -5.8% | 18.2% | -- |
| OP Growth (YoY) | 74.5% | -32.9% | 42.7% | 151.1% | 20.9% | 37.3% | -46.9% | -77.1% | -35.0% | 3.2% | 23.3% | -- | -- | -- | -- |
| OP Growth (QoQ) | 53.6% | 4.1% | 35.9% | -19.7% | -40.9% | 121.5% | 139.0% | -61.3% | -32.9% | -14.3% | 2.9% | 9.9% | 6.5% | 2.4% | -- |
| Profit Growth (YoY) | -- | -57.0% | 358.0% | 279.0% | 32.0% | 109.0% | -88.0% | -118.0% | -58.0% | -1.0% | 68.0% | 1381.0% | 42.0% | 98.0% | 278.0% |
| EPS Growth (YoY) | 205.2% | -56.9% | 354.7% | -14.0% | 32.8% | 108.9% | -87.9% | -61.6% | -57.6% | -0.4% | 68.0% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 114.5% | 14.6% | 134.8% | -47.1% | -69.7% | 1109.5% | -55.6% | -18.3% | -52.4% | -30.0% | 40.9% | -9.7% | 12.0% | 17.9% | -- |
| OP Margin | 7.4% | 5.2% | 6.1% | 5.2% | 5.4% | 9.8% | 5.5% | 2.5% | 6.7% | 9.0% | 12.1% | 11.3% | 9.9% | 8.8% | 10.2% |
| Net Margin | 3.3% | 1.6% | 1.8% | 0.9% | 1.4% | 4.8% | 0.5% | 1.2% | 1.6% | 2.9% | 4.8% | 3.3% | 3.5% | 3.0% | 3.0% |
| Material Cost % | 82.0% | 86.0% | 84.0% | 82.0% | 84.0% | 80.0% | 82.0% | 83.0% | 79.0% | 77.0% | 74.0% | 74.0% | 77.0% | 78.0% | 76.0% |
| Employee Cost % | 2.0% | 2.0% | 3.0% | 3.0% | 2.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% |
| P/S | 0.53 | 0.39 | 0.49 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 26.37 | 27.47 | 21.85 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.99 | 1.39 | 1.66 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Appointments/Re-aapointments of Directors
Outcome of Board Meeting
Unaudited Standalone and Consolidated Financial Results quarter ended June 30, 2026
Aarti Surfactants Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
Intimation regarding dispatch of Notice to Preference Shareholders
Disclosure under Reg.74(5) of SEBI (DP) Regulations, 2018
Outcome of Board Meeting held on July 3, 2026
Intimation of Record Date for redemption of Non Convertible Redeemable Preference Shares
Intimation of Board Meeting
Closure of Trading Window
Allotment of Equity Shares pursuant to ''Aarti Surfactants Limited Employee Stock Option Plan 2024''
Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015
Annual Secretarial Compliance Report for the year ended March 31, 2026.
Newspaper Publication of Financial Results.
Outcome of Board Meeting
Financial Results for the quarter and year ended March 31, 2026
Re-appointment of Cost Auditor & Internal Auditor for FY 2026-2027
Aarti Surfactants Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2026 ,inter alia, to consider and approve the Audited Financial Results ....
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
Newspaper Publication pertaining to Second 100 Days Campaign - "Saksham Niveshak"
Intimation Regarding Second 100-Day Campaign - ''Saksham Niveshak''
Closure of Trading Window
Intimation of approval of Reclassification of Promoter Group under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Newpaper Publications for Financial Results
Unaudited Financial Results for quarter and nine months ended December 31, 2025
Withdrawal of Promoter Re-Classification Application of Valiant Organics Limited.
Outcome of the Board Meeting
Aarti Surfactants Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/01/2026 ,inter alia, to consider and approve Un-Audited Financial Results ....
Compliance Certificate under Reg.74(5) of SEBI (DP) Regulations, 2018
Closure of Trading Window
Intimation of Credit Rating
Allotment of Equity Shares pursuant to exercise of Stock Options
Newspaper Publication of Financial Results
Re-constitution of Risk Management Committee.
Unaudited Financial Results for the Quarter and Half Year ended September 30, 2025.
Outcome of the Board Meeting
Aarti Surfactants Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 ,inter alia, to consider and approve Un-Audited Financial Results ....
Certificate under Reg.74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window
Change in Management
Scrutinizer''s Report and Voting Results
Investor Presentation made to shareholders at 7th AGM
Proceedings of 7th AGM
Intimation of Newspaper Advertisement regarding completion of dispatch of Annual Report for FY 2024-2025 and Notice of 7th AGM to the Members of the Company
Notice of 7th Annual General Meeting alongwith Annual Report of the Company for FY 2024-2025
Annual Report for FY 2024-2025
Record Date for Final Dividend for FY 2024-2025
Intimation of Newspaper Advertisements regarding 7th Annual General Meeting of the Company.
Newspaper Publication
Intimation on 100 days Campaign - Saksham Niveshak
Annual Reports
6Credit Ratings
6